DYNC2LI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.68490024552182E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.17240000047292E-07 |
Normal-vs-Stage2 |
1.854160E-02 |
Normal-vs-Stage3 |
2.23532303778029E-12 |
Normal-vs-Stage4 |
7.57183205024603E-12 |
Stage1-vs-Stage2 |
7.019600E-01 |
Stage1-vs-Stage3 |
1.631540E-04 |
Stage1-vs-Stage4 |
1.974970E-04 |
Stage2-vs-Stage3 |
3.683600E-02 |
Stage2-vs-Stage4 |
2.408500E-02 |
Stage3-vs-Stage4 |
7.041800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.67474931092693E-12 |
Normal-vs-AfricanAmerican |
2.346400E-02 |
Normal-vs-Asian |
8.805200E-01 |
Caucasian-vs-AfricanAmerican |
1.100120E-02 |
Caucasian-vs-Asian |
3.683400E-01 |
AfricanAmerican-vs-Asian |
5.915000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.32439664474782E-11 |
Normal-vs-Female |
1.61549999999622E-06 |
Male-vs-Female |
2.366000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.58510999999084E-05 |
Normal-vs-Age(41-60Yrs) |
7.73300000034283E-07 |
Normal-vs-Age(61-80Yrs) |
5.77760062014931E-11 |
Normal-vs-Age(81-100Yrs) |
7.433900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.426790E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.146400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.484800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.631800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.440800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.977200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.672600E-01 |
Normal-vs-Grade 2 |
8.24369999999908E-05 |
Normal-vs-Grade 3 |
5.99980065629779E-11 |
Normal-vs-Grade 4 |
9.99200722162641E-16 |
Grade 1-vs-Grade 2 |
1.323790E-01 |
Grade 1-vs-Grade 3 |
2.814100E-02 |
Grade 1-vs-Grade 4 |
4.70819999998096E-06 |
Grade 2-vs-Grade 3 |
1.880290E-02 |
Grade 2-vs-Grade 4 |
1.57669999278909E-09 |
Grade 3-vs-Grade 4 |
2.21659999999346E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.7867999999961E-05 |
Normal-vs-ccB subtype |
4.80038231387425E-12 |
ccA subtype-vs-ccB subtype |
3.85280000125832E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.25259999945216E-07 |
Normal-vs-N1 |
2.0578999999965E-05 |
N0-vs-N1 |
2.967500E-02 |
|
|